JIN MEDICAL INTERNATIONAL LT(NASDAQ:ZJYL) stock Fundamental Analysis

Fundamental Rating

Overall ZJYL gets a fundamental rating of 4 out of 10. We evaluated ZJYL against 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ZJYL get a neutral evaluation. Nothing too spectacular is happening here. ZJYL has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ZJYL was profitable.

In the past year ZJYL has reported a negative cash flow from operations.

ZJYL had positive earnings in each of the past 5 years.

Of the past 5 years ZJYL 4 years had a positive operating cash flow.

1.2 Ratios

The Return On Assets of ZJYL (8.03%) is better than 91.01% of its industry peers.

ZJYL has a better Return On Equity (12.76%) than 89.95% of its industry peers.

The Return On Invested Capital of ZJYL (7.79%) is better than 87.83% of its industry peers.

ZJYL had an Average Return On Invested Capital over the past 3 years of 9.49%. This is in line with the industry average of 7.87%.

		Industry Rank	Sector Rank
ROA	8.03%
ROE	12.76%
ROIC	7.79%

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

1.3 Margins

Looking at the Profit Margin, with a value of 15.64%, ZJYL belongs to the top of the industry, outperforming 93.12% of the companies in the same industry.

ZJYL's Profit Margin has declined in the last couple of years.

ZJYL has a Operating Margin of 15.48%. This is amongst the best in the industry. ZJYL outperforms 86.24% of its industry peers.

In the last couple of years the Operating Margin of ZJYL has declined.

ZJYL has a Gross Margin of 40.43%. This is in the lower half of the industry: ZJYL underperforms 67.72% of its industry peers.

In the last couple of years the Gross Margin of ZJYL has grown nicely.

		Industry Rank	Sector Rank
OM	15.48%
PM (TTM)	15.64%
GM	40.43%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZJYL is creating some value.

ZJYL has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, ZJYL has less shares outstanding

The debt/assets ratio for ZJYL is higher compared to a year ago.

2.2 Solvency

An Altman-Z score of 6.48 indicates that ZJYL is not in any danger for bankruptcy at the moment.

ZJYL's Altman-Z score of 6.48 is amongst the best of the industry. ZJYL outperforms 86.24% of its industry peers.

A Debt/Equity ratio of 0.39 indicates that ZJYL is not too dependend on debt financing.

ZJYL's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. ZJYL outperforms 46.56% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Altman-Z	6.48

ROIC/WACC1.07

WACC7.25%

2.3 Liquidity

A Current Ratio of 2.50 indicates that ZJYL has no problem at all paying its short term obligations.

ZJYL has a Current ratio (2.50) which is in line with its industry peers.

A Quick Ratio of 2.19 indicates that ZJYL has no problem at all paying its short term obligations.

ZJYL has a Quick ratio of 2.19. This is comparable to the rest of the industry: ZJYL outperforms 50.79% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.5
Quick Ratio	2.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ZJYL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.76%, which is quite good.

The Earnings Per Share has been growing slightly by 3.28% on average over the past years.

ZJYL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.57%.

ZJYL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.90% yearly.

EPS 1Y (TTM)15.76%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%66.67%

Revenue 1Y (TTM)18.57%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%35.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.23, which means the current valuation is very expensive for ZJYL.

Compared to the rest of the industry, the Price/Earnings ratio of ZJYL indicates a somewhat cheap valuation: ZJYL is cheaper than 70.90% of the companies listed in the same industry.

The average S&P500 Price/Earnings ratio is at 25.82. ZJYL is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	39.23
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZJYL indicates a somewhat cheap valuation: ZJYL is cheaper than 75.13% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	19.43

4.3 Compensation for Growth

The decent profitability rating of ZJYL may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)11.97

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ZJYL!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JIN MEDICAL INTERNATIONAL LT

NASDAQ:ZJYL (5/23/2025, 9:05:20 PM)

After market: 0.7841 0 (-0.05%)

0.7845

-0.01 (-1.2%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.23%

Inst Owner Change-47.52%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap122.81M

AnalystsN/A

Price TargetN/A

Short Float %1%

Short Ratio1.43

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	39.23
Fwd PE	N/A
P/S	5.23
P/FCF	N/A
P/OCF	N/A
P/B	4.26
P/tB	4.44
EV/EBITDA	19.43

EPS(TTM)0.02

EY2.55%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS0.15

BVpS0.18

TBVpS0.18

PEG (NY)N/A

PEG (5Y)11.97

Profitability

		Industry Rank	Sector Rank
ROA	8.03%
ROE	12.76%
ROCE	12.7%
ROIC	7.79%
ROICexc	23.55%
ROICexgc	25.79%
OM	15.48%
PM (TTM)	15.64%
GM	40.43%
FCFM	N/A

ROA(3y)9.9%

ROA(5y)10.46%

ROE(3y)14.18%

ROE(5y)16.34%

ROIC(3y)9.49%

ROIC(5y)11.9%

ROICexc(3y)22.47%

ROICexc(5y)22.7%

ROICexgc(3y)23.46%

ROICexgc(5y)23.49%

ROCE(3y)12.88%

ROCE(5y)15.84%

ROICexcg growth 3Y-2.39%

ROICexcg growth 5Y-7.19%

ROICexc growth 3Y-4.58%

ROICexc growth 5Y-8.54%

OM growth 3Y6.9%

OM growth 5Y-6.46%

PM growth 3Y7.26%

PM growth 5Y-2.67%

GM growth 3Y9.69%

GM growth 5Y1.86%

F-Score3

Asset Turnover0.51

Health

		Industry Rank	Sector Rank
Debt/Equity	0.39
Debt/FCF	N/A
Debt/EBITDA	2.84
Cap/Depr	324.82%
Cap/Sales	4.78%
Interest Coverage	15.2
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.5
Quick Ratio	2.19
Altman-Z	6.48

F-Score3

WACC7.25%

ROIC/WACC1.07

Cap/Depr(3y)128.78%

Cap/Depr(5y)88.37%

Cap/Sales(3y)1.86%

Cap/Sales(5y)1.33%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)15.76%

EPS 3Y5.52%

EPS 5Y3.28%

EPS Q2Q%66.67%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)18.57%

Revenue growth 3Y4.22%

Revenue growth 5Y2.9%

Sales Q2Q%35.29%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y26.9%

EBIT growth 3Y11.4%

EBIT growth 5Y-3.75%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-177.91%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-138.86%

OCF growth 3YN/A

OCF growth 5YN/A

JIN MEDICAL INTERNATIONAL LT (ZJYL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens